Glimepiride

Product NDC: 61442-116
11-digit product format: 614420116
Labeler code: 61442
Product ID: 61442-116_2386d706-9dab-4ae0-e063-6394a90a8a06
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Glimepiride
Dosage form: TABLET
Route: ORAL
Labeler: Carlsbad Technology, Inc.
Application: ANDA077911
Marketing category: ANDA
Marketing start: 2012-01-01
Substance: GLIMEPIRIDE
Active strength: 2 mg/1
Pharmacologic classes: Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A077911-001	GLIMEPIRIDE	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22
A077911-002	GLIMEPIRIDE	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22
A077911-003	GLIMEPIRIDE	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A077911-001	AB
A077911-002	AB
A077911-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077911-002	GLIMEPIRIDE	2MG	TABLET / ORAL	AB	2009-09-22	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077911-003	GLIMEPIRIDE	4MG	TABLET / ORAL	AB	2009-09-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077911-001	GLIMEPIRIDE	1MG	TABLET / ORAL	AB	2009-09-22	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A077911-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077911-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077911-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077911-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077911-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077911-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077911-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077911-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077911-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077911-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077911-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077911-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077911-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077911-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077911-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077911-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077911-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077911-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077911-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077911-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077911-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077911-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077911-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077911-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077911-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077911-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077911-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077911-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077911-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077911-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077911-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077911-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077911-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077911-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077911-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077911-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077911-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077911-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077911-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077911-001	AB	1	`1e350fbaab3a…`

Additional Listing Data#

Finished product: Yes
Brand name base: Glimepiride
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GLIMEPIRIDE	2 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6KY687524K	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
199245	Internal RxNorm lookup
199246	Internal RxNorm lookup
199247	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
72d88c6d-2f0a-4bf8-aa7f-1e1811794187	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
b890b964-2cf0-4439-aaf3-900c9e3e9e49	Product name	1	20160602
7611093e-8875-33d4-9e3c-f48c7e3af1e8	Product name	1	20140508
d36d861f-8a90-80cc-8935-1e6be9b4c7eb	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
61442-116-01	Glimepiride	100 in 1 BOTTLE	TABLET	100	11
61442-116-05	Glimepiride	500 in 1 BOTTLE	TABLET	500	11
61442-116-10	Glimepiride	1000 in 1 BOTTLE	TABLET	1000	11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61442-116-01	EA - Each	61442-116	dea3704e-f1cb-4652-8408-29176dbc0a2d	1	2012-07-24
61442-116-05	EA - Each	61442-116	09b98cc6-beb7-4ce3-8418-dc5d0c65aa8a	1	2016-06-14

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GLIMEPIRIDE	ACTIVE INGREDIENT	6KY687524K	GLIMEPIRIDE TABLET [CARLSBAD TECHNOLOGY, INC.]	7
GLIMEPIRIDE	ACTIVE MOIETY	6KY687524K	GLIMEPIRIDE TABLET [CARLSBAD TECHNOLOGY, INC.]	7
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	GLIMEPIRIDE TABLET [CARLSBAD TECHNOLOGY, INC.]	7
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	GLIMEPIRIDE TABLET [CARLSBAD TECHNOLOGY, INC.]	7
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	GLIMEPIRIDE TABLET [CARLSBAD TECHNOLOGY, INC.]	7
POLOXAMER 188	INACTIVE INGREDIENT	LQA7B6G8JG	GLIMEPIRIDE TABLET [CARLSBAD TECHNOLOGY, INC.]	7
POVIDONE K30	INACTIVE INGREDIENT	U725QWY32X	GLIMEPIRIDE TABLET [CARLSBAD TECHNOLOGY, INC.]	7
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	GLIMEPIRIDE TABLET [CARLSBAD TECHNOLOGY, INC.]	7
GLIMEPIRIDE	ACTIVE INGREDIENT	6KY687524K	GLIMEPIRIDE TABLET [NORTHWIND PHARMACEUTICALS, LLC]	1
GLIMEPIRIDE	ACTIVE MOIETY	6KY687524K	GLIMEPIRIDE TABLET [NORTHWIND PHARMACEUTICALS, LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61442-116	GLIMEPIRIDE TABLET [CARLSBAD TECHNOLOGY, INC.]	11	Current NDC, Legacy NDC, 3 package rows	20241004_72d88c6d-2f0a-4bf8-aa7f-1e1811794187.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Glimepiride	GLIMEPIRIDE	PD-Rx Pharmaceuticals, Inc.	647a146c-c752-4589-8619-aed5c720ca54	2026-03-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077911 application number: ANDA077911
Glimepiride	GLIMEPIRIDE	PD-Rx Pharmaceuticals, Inc.	ed7a3a8e-97dd-4a5a-9497-001acfd2f1f0	2026-03-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077911 application number: ANDA077911
Glimepiride	GLIMEPIRIDE	PD-Rx Pharmaceuticals, Inc.	f4ffb19e-6d65-49fd-83ce-514d38d9d97c	2025-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077911 application number: ANDA077911
Glimepiride	GLIMEPIRIDE	PD-Rx Pharmaceuticals, Inc.	11ae3189-6139-4470-95d5-72abc0f5b0d0	2025-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077911 application number: ANDA077911
Glimepiride	GLIMEPIRIDE	PD-Rx Pharmaceuticals, Inc.	2794f86b-d521-414b-8154-5dd1e2519653	2025-01-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077911 application number: ANDA077911
Glimepiride	GLIMEPIRIDE	Golden State Medical Supply, Inc.	4f83e203-c102-47fa-bb8e-4fc5541e0d6f	2024-12-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077911 application number: ANDA077911
Glimepiride	GLIMEPIRIDE	Carlsbad Technology, Inc.	72d88c6d-2f0a-4bf8-aa7f-1e1811794187	2024-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077911 application number: ANDA077911 ndc (product): 61442-116
Glimepiride	GLIMEPIRIDE	Aphena Pharma Solutions - Tennessee, LLC	00b9e312-921e-41e6-ad27-0a6ce87f8298	2019-02-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077911 application number: ANDA077911

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6KY687524K	GLIMEPIRIDE	93479-97-1	GLIMEPIRIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
199246	glimepiride 2 MG Oral Tablet	PSN	11ae3189-6139-4470-95d5-72abc0f5b0d0	22
199246	glimepiride 2 MG Oral Tablet	SCD	11ae3189-6139-4470-95d5-72abc0f5b0d0	22
199246	glimepiride 2 MG Oral Tablet	PSN	2794f86b-d521-414b-8154-5dd1e2519653	16
199246	glimepiride 2 MG Oral Tablet	SCD	2794f86b-d521-414b-8154-5dd1e2519653	16
199245	glimepiride 1 MG Oral Tablet	PSN	72d88c6d-2f0a-4bf8-aa7f-1e1811794187	11
199246	glimepiride 2 MG Oral Tablet	PSN	72d88c6d-2f0a-4bf8-aa7f-1e1811794187	11
199247	glimepiride 4 MG Oral Tablet	PSN	72d88c6d-2f0a-4bf8-aa7f-1e1811794187	11
199245	glimepiride 1 MG Oral Tablet	SCD	72d88c6d-2f0a-4bf8-aa7f-1e1811794187	11
199246	glimepiride 2 MG Oral Tablet	SCD	72d88c6d-2f0a-4bf8-aa7f-1e1811794187	11
199247	glimepiride 4 MG Oral Tablet	SCD	72d88c6d-2f0a-4bf8-aa7f-1e1811794187	11
199245	glimepiride 1 MG Oral Tablet	PSN	4f83e203-c102-47fa-bb8e-4fc5541e0d6f	6
199246	glimepiride 2 MG Oral Tablet	PSN	4f83e203-c102-47fa-bb8e-4fc5541e0d6f	6
199247	glimepiride 4 MG Oral Tablet	PSN	4f83e203-c102-47fa-bb8e-4fc5541e0d6f	6
199245	glimepiride 1 MG Oral Tablet	SCD	4f83e203-c102-47fa-bb8e-4fc5541e0d6f	6
199246	glimepiride 2 MG Oral Tablet	SCD	4f83e203-c102-47fa-bb8e-4fc5541e0d6f	6
199247	glimepiride 4 MG Oral Tablet	SCD	4f83e203-c102-47fa-bb8e-4fc5541e0d6f	6
199246	glimepiride 2 MG Oral Tablet	PSN	8b309577-5461-43eb-bb0b-0a5293ee9392	2
199246	glimepiride 2 MG Oral Tablet	PSN	5659e616-4858-4543-8e0b-c5477519f8fe	2
199246	glimepiride 2 MG Oral Tablet	SCD	8b309577-5461-43eb-bb0b-0a5293ee9392	2
199246	glimepiride 2 MG Oral Tablet	SCD	5659e616-4858-4543-8e0b-c5477519f8fe	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
61442-116-01	61442011601	100 TABLET in 1 BOTTLE (61442-116-01)	100 tablet	2012-01-01	0000-00-00	No	No	Current
61442-116-05	61442011605	500 TABLET in 1 BOTTLE (61442-116-05)	500 tablet	2012-01-01	0000-00-00	No	No	Current
61442-116-10	61442011610	1000 TABLET in 1 BOTTLE (61442-116-10)	1000 tablet	2012-01-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Glimepiride	REMEDYREPACK INC.	2025-09-29	HUMAN PRESCRIPTION DRUG LABEL	2
Glimepiride	PD-Rx Pharmaceuticals, Inc.	2025-01-08	HUMAN PRESCRIPTION DRUG LABEL	22
Glimepiride	PD-Rx Pharmaceuticals, Inc.	2025-01-03	HUMAN PRESCRIPTION DRUG LABEL	16
Glimepiride	Golden State Medical Supply, Inc.	2024-12-05	HUMAN PRESCRIPTION DRUG LABEL	6
Glimepiride	Carlsbad Technology, Inc.	2024-10-02	HUMAN PRESCRIPTION DRUG LABEL	11
Glimepiride	A-S Medication Solutions	2019-04-30	HUMAN PRESCRIPTION DRUG LABEL	7
Glimepiride	Aidarex Pharmaceuticals LLC \| Aidarex Pharmaceuticals	2018-05-31	HUMAN PRESCRIPTION DRUG LABEL	2
Glimepiride	Liberty Pharmaceuticals, Inc.	2016-08-03	HUMAN PRESCRIPTION DRUG LABEL	2
GLIMEPIRIDE	Northwind Pharmaceuticals, LLC	2015-03-24	HUMAN PRESCRIPTION DRUG LABEL	1